A novel molecular mechanism to account for the action of botulinum toxin against lateral epicondylitis

International Journal of Rheumatic Diseases

Volumn 11, Issue 1, 2008, Pages 83-84

  Namazi, Hamid ^a,b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; CALCITONIN GENE RELATED PEPTIDE; CYTOKINE; INTERLEUKIN 1ALPHA; NEUROPEPTIDE; SUBSTANCE P;

CLOSTRIDIUM BOTULINUM; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; INFLAMMATORY INFILTRATE; LETTER; MOLECULAR MECHANICS; NOCICEPTION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TENNIS ELBOW;

EID: 54949102087     PISSN: 17561841     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2008.00338.x     Document Type: Letter

References (14)

1. Wong SM, Hui AC, Tong PY, et al. (2005) Treatment of lateral epicondylitis with Botulinum toxin. A randomized, double blind, placebo controlled trial. Ann Intern Med 143, 793-7.
2. Coonrad RW, Hooper WR (1973) Tennis elbow: Its course, natural history, conservative and surgical management. J Bone Joint Surg Am 55, 1177-82.
3. Nirschl RP (1992) Elbow tendinitis/tennis elbow. Clin Sports Med 11, 851-70.
4. Regan W, Wold LE, Coonrad R, et al. (1992) Microscopic histopathology of chronic refractory lateral epicondylitis. Am J Sports Med 20, 746-59.
5. Ljung BO, Forsgren S, Fridén J (1999) Substance P and calcitonin gene-related peptide expression at the extensor carpi radialis brevis muscle origin: Implications for the etiology of tennis elbow. J Orthop Res 17, 554-9.
6. Harker E, Theodorsson E, Lundeberg T (1998) An experimental model of tennis elbow in rats: A study of contribution of the nervous system. Inflammation 22, 435-44.
7. Harker E, Theodorsson E, Lundeberg T (1997) An experimental study of the neurogenic and the immunological contribution to 'tennis elbow' in rats. Inflammation 21, 35-44.
8. Uchio Y, Ochi M, Ryoke K, et al. (2002) Expression of neuropeptides and cytokines at the extensor carpi radialis brevis muscle origin. J Shoulder Elbow Surg 11, 570-5.
9. Placzek R, Drescher W, Deuretzbacher G, et al. (2007) Treatment of chronic radial epicondylitis with botulinum toxin A. A double-blind, placebo-controlled, randomized multicenter study. J Bone Joint Surg Am 89, 255-60.
10. Monnier G, Tatu L, Michel F (2006) New indications for botulinum toxin in rheumatology. Joint Bone Spine 73, 667-71.
11. Holbourn KP, Sutton JM, Shore C, et al. (2005) Molecular recognition of an ADP-ribosyl transferase; clostridium botulinum C3 exoenzyme. Proc Natl Acad Sci 102, 535-64.
12. Harmey D, Stenbeck G, Nobes CD, et al. (2004) Regulation of osteoblast differentiation by Pasteurella multocida toxin (PMT): A role for Rho GTPase in bone formation. J Bone Miner Res 19, 661-7.
13. Singh R, Wang B, Shirraikar A, et al. (1999) The IL-1 receptor and Rho directly associate to drive cell activation in inflammation. J Clin Invest 103, 1561-70.
14. Dolly JO, Aoki KR (2006) The structure and mode of action of different botulinum toxins. Eur J Neurol 13, 1-9.